| Intratumor heterogeneity: the rosetta stone of therapy resistance A Marusyk, M Janiszewska, K Polyak Cancer cell 37 (4), 471-484, 2020 | 702 | 2020 |
| Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer S Shu, CY Lin, HH He, RM Witwicki, DP Tabassum, JM Roberts, ... Nature 529 (7586), 413-417, 2016 | 625 | 2016 |
| Cell adhesion in cancer: Beyond the migration of single cells M Janiszewska, MC Primi, T Izard Journal of biological chemistry 295 (8), 2495-2505, 2020 | 551 | 2020 |
| EZH2 is essential for glioblastoma cancer stem cell maintenance ML Suvà, N Riggi, M Janiszewska, I Radovanovic, P Provero, JC Stehle, ... Cancer research 69 (24), 9211-9218, 2009 | 548 | 2009 |
| Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells M Janiszewska, ML Suvà, N Riggi, RH Houtkooper, J Auwerx, ... Genes & development 26 (17), 1926-1944, 2012 | 471 | 2012 |
| Classifying the evolutionary and ecological features of neoplasms CC Maley, A Aktipis, TA Graham, A Sottoriva, AM Boddy, M Janiszewska, ... Nature Reviews Cancer 17 (10), 605-619, 2017 | 412 | 2017 |
| EWS-FLI-1 modulates miRNA145 and SOX2 expression to initiate mesenchymal stem cell reprogramming toward Ewing sarcoma cancer stem cells N Riggi, ML Suvà, C De Vito, P Provero, JC Stehle, K Baumer, L Cironi, ... Genes & development 24 (9), 916-932, 2010 | 347 | 2010 |
| IMPs: an RNA-binding protein family that provides a link between stem cell maintenance in normal development and cancer N Degrauwe, ML Suvà, M Janiszewska, N Riggi, I Stamenkovic Genes & development 30 (22), 2459-2474, 2016 | 278 | 2016 |
| In situ single-cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2-positive breast cancer M Janiszewska, L Liu, V Almendro, Y Kuang, C Paweletz, RA Sakr, ... Nature genetics 47 (10), 1212-1219, 2015 | 192 | 2015 |
| Subclonal cooperation drives metastasis by modulating local and systemic immune microenvironments M Janiszewska, DP Tabassum, Z Castaño, S Cristea, KN Yamamoto, ... Nature cell biology 21 (7), 879-888, 2019 | 141 | 2019 |
| Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes A Marusyk, DP Tabassum, M Janiszewska, AE Place, A Trinh, AI Rozhok, ... Cancer research 76 (22), 6495-6506, 2016 | 139 | 2016 |
| The RNA binding protein IMP2 preserves glioblastoma stem cells by preventing let-7 target gene silencing N Degrauwe, TB Schlumpf, M Janiszewska, P Martin, A Cauderay, ... Cell reports 15 (8), 1634-1647, 2016 | 136 | 2016 |
| Let-7a is a direct EWS-FLI-1 target implicated in Ewing's sarcoma development C De Vito, N Riggi, ML Suva, M Janiszewska, J Horlbeck, K Baumer, ... PloS one 6 (8), e23592, 2011 | 98 | 2011 |
| HER2 heterogeneity as a predictor of response to neoadjuvant T-DM1 plus pertuzumab: Results from a prospective clinical trial. O Metzger Filho, G Viale, L Trippa, T Li, DA Yardley, IA Mayer, ... Journal of Clinical Oncology 37 (15_suppl), 502-502, 2019 | 90 | 2019 |
| The microcosmos of intratumor heterogeneity: the space-time of cancer evolution M Janiszewska Oncogene 39 (10), 2031-2039, 2020 | 69 | 2020 |
| YAP-mediated recruitment of YY1 and EZH2 represses transcription of key cell-cycle regulators S Hoxha, A Shepard, S Troutman, H Diao, JR Doherty, M Janiszewska, ... Cancer research 80 (12), 2512-2522, 2020 | 58 | 2020 |
| Epigenetic features of human mesenchymal stem cells determine their permissiveness for induction of relevant transcriptional changes by SYT-SSX1 L Cironi, P Provero, N Riggi, M Janiszewska, D Suva, ML Suva, V Kindler, ... PloS one 4 (11), e7904, 2009 | 57 | 2009 |
| TRPS1 is a lineage-specific transcriptional dependency in breast cancer RM Witwicki, MB Ekram, X Qiu, M Janiszewska, S Shu, M Kwon, A Trinh, ... Cell reports 25 (5), 1255-1267. e5, 2018 | 55 | 2018 |
| Transportin regulates nuclear import of CD44 M Janiszewska, C De Vito, MA Le Bitoux, C Fusco, I Stamenkovic Journal of Biological Chemistry 285 (40), 30548-30557, 2010 | 55 | 2010 |
| The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+ breast cancer M Janiszewska, S Stein, O Metzger Filho, J Eng, NL Kingston, NW Harper, ... JCI insight 6 (11), 2021 | 41 | 2021 |